Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma - Lemonnier, François; Safar, Violaine; Beldi-Ferchiou, Asma; Cottereau, Anne-Ségolène; Bachy, Emmanuel; Cartron, Guillaume; Fataccioli, Virginie; Pelletier, Laura; Robe, Cyrielle; Letourneau, Audrey; Missiaglia, Edoardo; Fourati, Slim; et al. (Blood advances, 2021)
Keywords: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols - adverse effects; Cancer; Hematology; Human health and pathology; Humans; Lenalidomide; Life Sciences; Lymphoid Neoplasia; Lymphoma, T-Cell; Middle Aged; Pharmaceutical sciences; Pharmacology; Prospective Studies; Rituximab; Santé publique et épidémiologie